In our latest blog post we meet our Director, Phil Quinlan, to find out more about his role and future work at the UKCRC TDCC.
Spotlight on: Erik Steinfelder Erik Steinfelder is Director General of BBMRI-ERIC. Erik has completed a Bsc in Analytical Chemistry and a course in Foundations of Management. In 2008, he joined Thermo Fisher Scientific and as first Biobank Commercial Leader EMEA, he went on to head the complete biobank portfolio and range of activities. Additionally, between[…]
Spotlight on: Dr Sharon King Dr Sharon King is Manager of the Tayside Biorepository in Dundee. The Tayside Biorepository is part of a wider Scottish Biorepository Network supported by the Chief Scientist Office. Sharon has worked within a variety of translational based projects using human tissues, including PLK1 repression in breast cancer where she was awarded the[…]
Spotlight on: Professor Andrew Morris Professor Andrew Morris is the inaugural Director of Health Data Research UK (HDR UK). He is seconded from his position as Professor of Medicine, and Vice Principal of Data Science at the University of Edinburgh. Prior to this Andrew was Dean of Medicine at the University of Dundee and Chief[…]
Spotlight on: Matt Styles In our latest blog post we meet software developer, Matt Styles, to find out more about his role and future work at the UKCRC TDCC. What is your role within the UKCRC TDCC and what does it involve? My job title is formally ‘Senior Research Developer’, though I’ll admit to not[…]
Spotlight on: Emma Lawrence In our latest blog post we meet Engagement Manager, Research, Dr Emma Lawrence to find out more about her role and future work at the UKCRC Tissue Directory and Coordination Centre (UKCRC TDCC). What is your role and what does it involve? My job title is Engagement Manager for Research. It’s[…]
Spotlight on: Ana Rio-Machin Job title: Postdoctoral Researcher at Barts Cancer Institute (BCI), Queen Mary University of London Research Project: Ana researches the genetic alterations (mutations) that are inherited in families who have leukaemia without a known cause, within a Bloodwise funded programme; ‘Acute Myeloid Leukaemia (AML) familial cases, where two or more affected individuals[…]